Top 10 Fastest-Growing Mid-Cap Stocks: DRC, GOLD, FLS, HGSI, AEG, UTHR, CTCM, AIXG, CX, AMLN (Sep 02, 2010)

Below are the top 10 fastest-growing Mid-Cap stocks, based on the average long-term earnings growth rate estimated by Wall Street analysts.

Dresser-Rand Group Inc. (NYSE:DRC) is the 1st fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 186.9%. This number is based on the average estimate of 1 brokerage analyst(s). Randgold Resources Ltd. (ADR) (NASDAQ:GOLD) is the 2nd fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 181.8%. This number is based on the average estimate of 2 brokerage analyst(s). Flowserve Corporation (NYSE:FLS) is the 3rd fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 149.9%. This number is based on the average estimate of 2 brokerage analyst(s). Human Genome Sciences (NASDAQ:HGSI) is the 4th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 106.7%. This number is based on the average estimate of 1 brokerage analyst(s). AEGON N.V. (ADR) (NYSE:AEG) is the 5th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 70.3%. This number is based on the average estimate of 1 brokerage analyst(s).

United Therapeutics Corporation (NASDAQ:UTHR) is the 6th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 67.2%. This number is based on the average estimate of 8 brokerage analyst(s). CTC Media, Inc. (NASDAQ:CTCM) is the 7th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 66.2%. This number is based on the average estimate of 1 brokerage analyst(s). Aixtron AG (ADR) (NASDAQ:AIXG) is the 8th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 64.2%. This number is based on the average estimate of 2 brokerage analyst(s). Cemex SAB de CV (ADR) (NYSE:CX) is the 9th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 61.7%. This number is based on the average estimate of 1 brokerage analyst(s). Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) is the 10th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 57.3%. This number is based on the average estimate of 2 brokerage analyst(s).